NCT00740025已完成不适用
A Prospective Randomized Study of QD vs BID Dosing in ART
Virginia Center for Reproductive Medicine1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2006年1月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- Ongoing pregnancy
研究概览
简要总结
This is a prospective randomized study evaluating dosing frequency of gonadotropin administration in ART cycles.
详细描述
Using once daily or bid dosing of gonadotropins in ART has been arbitrary with no studies showing whether splitting the medication dose improves ART parameters. This study was undertaken to provide an answer to this important question.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 21 Years 至 39 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •women < 40 undergoing ART
排除标准
- •women > 40
- •endometriomas
- •severe cervical stenosis
- •testicular sperm
结局指标
主要结局
Ongoing pregnancy
时间窗: 1 year
次要结局
- peak estradiol, number of follicles, number of oocytes, implantation rate, multiple pregnancy rate(1 year)
研究者
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
2 期
Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With DemodexDemodex Infestation of EyelidDemodectic BlepharitisBlepharitisMeibomian Gland DysfunctionNCT06054217Tarsus Pharmaceuticals, Inc.36
终止
4 期
Type of Gonadotropin and Embryo Kinetics of DevelopmentInfertilityNCT02402192IVI Madrid201
已完成
2 期
Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult WomenNocturiaNCT01684800Ferring Pharmaceuticals178
已完成
2 期
Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult MenNocturiaNCT01694498Ferring Pharmaceuticals183
已完成
1 期
Intermittent Selumetinib for Uveal MelanomaUveal MelanomaNCT02768766Shaheer A. Khan42